3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
35
Neoplasms
23
Motor Activity
11
Stomach Neoplasms
7
Pain, Postoperative
7
Lung Neoplasms
7
Fatigue
7
Colorectal Neoplasms
7
Pain
5
Anxiety Disorders
5
Polycystic Ovary Syndrome
4
Depression
4
Carcinoma, Hepatocellular
4
Uterine Cervical Neoplasms
3
Thyroid Neoplasms
3
Stomatitis
3
Sleep Initiation and Maintenance Disorders
3
Rectal Neoplasms
3
Prostatic Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Malnutrition
3
Liver Neoplasms
3
Leukemia, Myeloid, Acute
3
Colonic Neoplasms
3
Agnosia
3
Vomiting
2
Urinary Incontinence
2
Squamous Cell Carcinoma of Head and Neck
2
Parasomnias
2
Ovarian Neoplasms
2
Interventions
Etoposide
19
Carboplatin
19
Ifosfamide
16
Filgrastim
16
Peripheral Blood Stem Cell Transplantation
13
Paclitaxel
13
Cisplatin
12
Cyclophosphamide
10
Thiotepa
7
Therapeutics
5
Radiotherapy
5
Melphalan
5
Busulfan
5
Magnetic Resonance Spectroscopy
4
Gemcitabine
4
Flow Cytometry
4
pegfilgrastim
3
etoposide phosphate
3
Surveys and Questionnaires
3
Psychiatric Rehabilitation
3
Methylprednisolone
3
Methods
3
Immunologic Techniques
3
Granulocyte Colony-Stimulating Factor
3
Epirubicin
3
Dexamethasone
3
Blood Specimen Collection
3
Bleomycin
3
tremelimumab
2
durvalumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Testicular Neoplasms
×
Control Groups
×
Clear all
NCT02577172
2017-01-26
TAST
Oslo University Hospital
Phase NA
Terminated
19 enrolled